Platelet Rich Plasma and Recurrent Implantation Failure

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 16, 2017

Primary Completion Date

November 17, 2021

Study Completion Date

May 21, 2022

Conditions
Recurrent Implantation Failure
Interventions
OTHER

Intra uterine infusion of platelet rich plasma

Platelet Rich Plasma (PRP) is a blood product with a high platelet and a normal plasma fibrinogen level. Given the effective factors of RPR in repairing damaged tissues, its application in the field of regenerative medicine has widely been interested over the last three decades. According to the literature, PRP is an effective and safe treatment in the fields of orthopaedics, dermatology, ophthalmology, and repair of neurological, vascular, and connective tissue damage, but its application in the field of infertility is limited to a few pilot studies in which the effects of PRP on endometrium and recurrent implantation failure (RIF) were investigated.

Trial Locations (1)

16635-148

Royan Institute, Tehran

All Listed Sponsors
lead

Royan Institute

OTHER_GOV

NCT03996837 - Platelet Rich Plasma and Recurrent Implantation Failure | Biotech Hunter | Biotech Hunter